No association of FcγRIIa, FcγRIIIa and FcγRIIIb polymorphisms with MS

Journal of Neuroimmunology

Volumn 140, Issue 1-2, 2003, Pages 210-215

  Breij, Esther C W ^a   Van Der Pol, W Ludo ^b   Van Winsen, Lisa ^a   Jansen, Mark D ^b   Dijkstra, Christine D ^a   Van De Winkel, Jan G J ^b,c   Uitdehaag, Bernard M J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c GENMAB   (Netherlands)

Author keywords

Fc receptors; Multiple sclerosis; Polymorphisms

Indexed keywords

FC RECEPTOR; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0037967464     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(03)00207-8     Document Type: Article

References (34)

1. Bredius R.G., Fijen C.A., De Haas M., Kuijper E.J., Weening R.S., Van de Winkel J.G., Out T.A. Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology. 83:1994;624-630.
2. Carlsson L.E., Santoso S., Baurichter G., Kroll H., Papenberg S., Eichler P., Westerdaal N.A., Kiefel V., van de Winkel J.G., Greinacher A. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood. 92:1998;1526-1531.
3. Cepok S., Jacobsen M., Schock S., Omer B., Jaekel S., Boddeker I., Oertel W.H., Sommer N., Hemmer B. Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain. 124:2001;2169-2176.
4. Cross A.H., Trotter J.L., Lyons J. B cells and antibodies in CNS demyelinating disease. J. Neuroimmunol. 112:2001;1-14.
5. de Haas M., Kleijer M., van Zwieten R., Roos D., von dem Borne A.E. Neutrophil Fc gamma RIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood. 86:1995;2403-2413.
6. Duits A.J., Bootsma H., Derksen R.H., Spronk P.E., Kater L., Kallenberg C.G., Capel P.J., Westerdaal N.A., Spierenburg G.T., Gmelig-Meyling F.H.et al. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 38:1995;1832-1836.
7. Ebers G.C., Dyment D.A. Genetics of multiple sclerosis. Semin. Neurol. 18:1998;295-299.
8. Giovannoni G., Hartung H.P. The immunopathogenesis of multiple sclerosis and Guillain-Barre syndrome. Curr. Opin. Neurol. 9:1996;165-177.
9. Huizinga T.W., Kleijer M., Tetteroo P.A., Roos D., von dem Borne A.E. Biallelic neutrophil Na-antigen system is associated with a polymorphism on the phospho-inositol-linked Fc gamma receptor III (CD16). Blood. 75:1990;213-217.
10. Izquierdo G., Angulo S., Garcia-Moreno J.M., Gamero M.A., Navarro G., Gata J.M., Ruiz-Pena J.L., Paramo M.D. Intrathecal IgG synthesis: marker of progression in multiple sclerosis patients. Acta Neurol. Scand. 105:2002;158-163.
11. Kieseier B.C., Storch M.K., Archelos J.J., Martino G., Hartung H.P. Effector pathways in immune mediated central nervous system demyelination. Curr. Opin. Neurol. 12:1999;323-336.
12. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452.
13. Leppers-van de Straat F.G., van der Pol W.L., Jansen M.D., Sugita N., Yoshie H., Kobayashi T., van de Winkel J.G. A novel PCR-based method for direct Fc gamma receptor IIIa (CD16) allotyping. J. Immunol. Methods. 242:2000;127-132.
14. Linington C., Bradl M., Lassmann H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 130:1988;443-454.
15. Lucchinetti C., Bruck W., Parisi J., Scheithauer B., Rodriguez M., Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:2000;707-717.
16. Maxwell K.F., Powell M.S., Hulett M.D., Barton P.A., McKenzie I.F., Garrett T.P., Hogarth P.M. Crystal structure of the human leukocyte Fc receptor, Fc gammaRIIa. Nat. Struct. Biol. 6:1999;437-442.
17. Morgan A.W., Griffiths B., Ponchel F., Montague B.M., Ali M., Gardner P.P., Gooi H.C., Situnayake R.D., Markham A.F., Emery P., Isaacs J.D. Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groups. Arthritis Rheum. 43:2000;2328-2334.
18. Myhr K.M., Raknes G., Nyland H., Vedeler C. Immunoglobulin G Fc-receptor (FcgammaR) IIA and IIIB polymorphisms related to disability in MS. Neurology. 52:1999;1771-1776.
19. Parren P.W., Warmerdam P.A., Boeije L.C., Arts J., Westerdaal N.A., Vlug A., Capel P.J., Aarden L.A., van de Winkel J.G. On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2. J. Clin. Invest. 90:1992;1537-1546.
20. Ravetch J.V., Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19:2001;275-290.
21. Salmon J.E., Edberg J.C., Brogle N.L., Kimberly R.P. Allelic polymorphisms of human Fc gamma receptor IIA and Fc gamma receptor IIIB. Independent mechanisms for differences in human phagocyte function. J. Clin. Invest. 89:1992;1274-1281.
22. Salmon J.E., Millard S., Schachter L.A., Arnett F.C., Ginzler E.M., Gourley M.F., Ramsey-Goldman R., Peterson M.G., Kimberly R.P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J. Clin. Invest. 97:1996;1348-1354.
23. Sanders L.A., van de Winkel J.G., Rijkers G.T., Voorhorst-Ogink M.M., de Haas M., Capel P.J., Zegers B.J. Fc gamma receptor IIa (CD32) heterogeneity in patients with recurrent bacterial respiratory tract infections. J. Infect. Dis. 170:1994;854-861.
24. Schrijver H.M., Crusius J.B.A., Uitdehaag B.M.J., Garcia Gonzalez M.A., Kostense P.J., Polman M.D., Pena A.S. Association of interleukin-1B and interleukin-1 receptor antagonist genes with disease severity. Neurology. 52:1999;595-599.
25. Smyth L.J., Snowden N., Carthy D., Papasteriades C., Hajeer A., Ollier W.E. Fc gamma RIIa polymorphism in systemic lupus erythematosus. Ann. Rheum. Dis. 56:1997;744-746.
26. Storch M.K., Piddlesden S., Haltia M., Iivanainen M., Morgan P., Lassmann H. Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination. Ann. Neurol. 43:1998;465-471.
27. van der Pol W., van de Winkel J.G. IgG receptor polymorphisms: risk factors for disease. Immunogenetics. 48:1998;222-232.
28. van der Pol W.L., Huizinga T.W., Vidarsson G., van der Linden M.W., Jansen M.D., Keijsers V., de Straat F.G., Westerdaal N.A., de Winkel J.G., Westendorp R.G. Relevance of Fcgamma receptor and interleukin-10 polymorphisms for meningococcal disease. J. Infect. Dis. 184:2001;1548-1555.
29. van Schie R.C., Wilson M.E. Evaluation of human FcgammaRIIA (CD32) and FcgammaRIIIB (CD16) polymorphisms in Caucasians and African-Americans using salivary DNA. Clin. Diagn. Lab. Immunol. 7:2000;676-681.
30. Warmerdam P.A., van de Winkel J.G., Gosselin E.J., Capel P.J. Molecular basis for a polymorphism of human Fc gamma receptor II (CD32). J. Exp. Med. 172:1990;19-25.
31. Warren K.G., Catz I. An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis. Eur. Neurol. 42:1999;95-104.
32. Wingerchuk D.M., Lucchinetti C.F., Noseworthy J.H. Multiple sclerosis: current pathophysiological concepts. Lab. Invest. 81:2001;263-281.
33. Xiao B.G., Linington C., Link H. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls. J. Neuroimmunol. 31:1991;91-96.
34. Yee A.M., Phan H.M., Zuniga R., Salmon J.E., Musher D.M. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin. Infect. Dis. 30:2000;25-28.